| Literature DB >> 35953905 |
Yan Zhang1,2,3, Xiang Chen1,2,3, Zhinan Zhou1,2,3, Xingzhou Tian1,2,3, Peifang Yang1,2,3, Kaibing Fu1,2,3.
Abstract
Abnormal expression of CYP19A1, a gene related to steroid hormone synthesis, causes steroid hormone disruption and leads to abnormal ovulation in granulosa cells. However, the exact mechanism of CYP19A1 regulation is unclear. In this study, we confirmed the localization of CYP19A1 in goat ovarian tissues using immunohistochemistry. Subsequently, we investigated the effects of CYP19A1 on granulosa cell proliferation, steroid hormone secretion, and expression of candidate genes for multiparous traits by overexpressing and silencing CYP19A1 in goat granulosa cells (GCs). The immunohistochemistry results showed that CYP19A1 was expressed in all types of follicular, luteal, and granulosa cells, with subcellular localization results revealing that CYP19A1 protein was mainly localized in the cytoplasm and nucleus. Overexpression of CYP19A1 significantly increased the mRNA levels of CYP19A1, FSHR, and INHBA, which are candidate genes for multiple birth traits in goats. It also promoted cell proliferation, PCNA and Cyclin E mRNA levels in granulosa cells, and secretion of estrogen and progesterone. However, it inhibited the mRNA levels of STAR, CYP11A1, and 3βSHD, which are genes related to steroid synthesis. Silencing CYP19A1 expression significantly reduced CYP19A1, FSHR, and INHBA mRNA levels in granulosa cells and inhibited granulosa cell proliferation and PCNA and Cyclin E mRNA levels. It also reduced estrogen and progesterone secretion but enhanced the mRNA levels of STAR, CYP11A1, and 3βSHD. CYP19A1 potentially influenced the lambing traits in goats by affecting granulosa cell proliferation, hormone secretion, and expression of candidate genes associated with traits for multiple births.Entities:
Keywords: CYP19A1; cell proliferation; follicular granulosa cells; goats; lambing traits
Year: 2022 PMID: 35953905 PMCID: PMC9367365 DOI: 10.3390/ani12151911
Source DB: PubMed Journal: Animals (Basel) ISSN: 2076-2615 Impact factor: 3.231
CYP19A1 shRNA and CYP19A1 pEGFP primer information.
| Gene Name | Primer Sequences (5′-3′) |
|---|---|
| sh1-CYP19A1 | F: CACCGCGGTCACCAACATAATCAGCTTCAAGAGAGCTGATTATGTTGGTGACCGCTTTTTTG |
| sh2-CYP19A1 | F: CACCGACCAGAATATAGGTTTCAATTTCAAGAGAATTGAAACCTATATTCTGGTCTTTTTTG |
| sh3-CYP19A1 | F: CACCGAGGCAATGATGAGGGAAATCTTCAAGAGAGATTTCCCTCATCATTGCCTCTTTTTTG |
| sh4-CYP19A | F: CACCGCTGTGCAGAAAGTATGAAAATTCAAGAGATTTTCATACTTTCTGCACAGCTTTTTTG |
| sh-NC | F: CACCGTTCTCCGAACGTGTCACGTTTCAAGAGAACGTGACACGTTCGGAGAATTTTTTG |
| pEGFP-N3-CYP19A1 | (BglII) F: CGTCAGATCCGCTAGCGCTACCGGACTC |
The pEGFPpEGFP-N3-CYP19A1 vector sequence is shown in red for the homology arm, bold black for the digestion site, and black for the target fragment.
Related gene real-time fluorescent primer information.
| Gene Name | Primer Sequences (5′-3′) | Login ID | Fragment Size (bp) |
|---|---|---|---|
|
| F: GCTCTTGGTCCTCATCATTTTATTC | NC_022298.2 | 143 |
|
| F: TGTTATGTCCCTCCTTGTGCTC | NM_001285644.1 | 122 |
|
| F: GTAGCCGTGTCATTGCGACTCC | XM_005688167.3 | 145 |
|
| F: AAGGTGGTGGATGCTCGAAA | NM_001285581.1 | 125 |
|
| F: CCCAAGGCATTACAATGT | NM_001314145.1 | 169 |
|
| F: GGTCCCCGAGACTTTGTGAG | XM_013975437.2 | 262 |
|
| F: AGACCAGAAGTTCGGGAGGAA | NM_001285716.1 | 292 |
|
| F: CTCCAGAGGCAATAAAGAA | NM_001287574.1 | 145 |
|
| F: GATGTCGGCTGCTTAGAAT | XM_018062248.1 | 104 |
| F: AGATGTGGATCAGCAAGCAG | NM_001297986.1 | 139 |
Figure 1Follicular granulosa cell culture identification. (A1–D1) Immunofluorescence result of granulosa cells observed at 400×. (A2–D2) Immunofluorescence result of granulosa cells observed at 200×. (C1) Map combining (A1 + B1), (C2) map combining (A2 + B2), and (D1,D2) blank controls without FSHR antibody staining. (A1,A2) Granule nuclear staining, (B1,B2) cytoplasmic staining, and (C1,C2) nuclear and cytoplasmic synthesis maps.
Figure 2HE staining of ovarian tissue: (A–D) 400×, (E) 200×, (F) 50×. (A) Corpus luteum; (B) primordial follicle cells; (C) secondary follicle; (D) tertiary follicle; (E) atretic follicle; (F) mature large follicle group.
Figure 3CYP19A1 protein subcellular localization results, 400×.
Figure 4CYP19A1 protein localization, 400×. C (C1–C3) Diagram combining A (A1–A3) + B (B1–B3); (D1–D3) blank control (n = 3).
Figure 5Validation of CYP19A1 overexpression and silencing expression vector efficiency and results of genetic assays for reproduction-related indicators. (A) pEGFP-N3-CYP19A1 efficiency validation; (B) sh1-4-CYP19A1 efficiency validation; (C) results of overexpression of CYP19A1; (D) results of silencing CYP19A1. ** indicates highly significant difference (p < 0.01). The mRNA levels of target genes were normalized with housekeeping gene (β-actin, 139 bp) and expressed as 2−∆∆CT using samples on pEGFP-N3 or sh-NC as calibrator. Results are indicated by means ± SD (n = 3).
Figure 6Effects of altering CYP19A1 on proliferation of granulosa cells. (A) Overexpression of CYP19A1 promotes PCNA and Cyclin E mRNA expression levels; (B) overexpression of CYP19A1 promotes granulosa cell proliferation; (C) silencing of CYP19A1 inhibits PCNA and Cyclin E mRNA expression levels; (D) silencing of CYP19A1 inhibits granulosa cell proliferation. The mRNA levels of target genes were normalized with housekeeping gene (β-actin, 139 bp) and expressed as 2−∆∆CT using samples on pEGFP-N3 or sh-NC as a calibrator. Results are indicated by means ± SD (n = 3). ** indicates highly significant difference (p < 0.01), * indicates significant difference (p < 0.05).
Figure 7Effects of altering CYP19A1 gene on granulosa cell proliferation. (A) Overexpression of CYP19A1 promotes progesterone secretion in granulosa cells; (B) silencing CYP19A1 inhibits progesterone secretion in granulosa cells; (C) overexpression of CYP19A1 promotes mRNA expression levels of steroid-related genes; (D) overexpression of CYP19A1 promotes estrogen secretion in granulosa cells; (E) silencing of CYP19A1 inhibits estrogen secretion in granulosa cells; (F) silencing of CYP19A1 suppression inhibits the mRNA expression level of steroid-related genes. ** indicates highly significant difference (p < 0.01), * indicates significant difference (p < 0.05).